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Abstract: 
A previous report claimed no evidence of transgenerational epigenetic inheritance in a mouse 
model of in utero environmental exposure, based on the observation that gene expression 
changes observed in the germ cells of G1 and G2 male fetus were not in the same direction. A 
subsequent data reanalysis however showed a statistically significant overlap between G1 and 
G2 genes irrespective of direction, leading to the suggestion that, as phenotypic variability in 
epigenetic transmission has been observed in several other examples also, the above report 
provided evidence in favor of, not against, transgenerational inheritance. This criticism has 
recently been questioned. Here, it is shown that the questions raised are based not only on 
incorrect statistical calculations but also on wrong premise that gene expression changes do not 
constitute a phenotype.                 
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Introduction 
Iqbal et al. [1] previously claimed, based mainly on gene expression data, that endocrine 
disrupting chemicals (EDCs) do not cause transgenerational effects in mammals. In brief, the 
authors treated G0 female mice with the EDCs vinclozolin (VZ), and di-(2-ethylhexyl)phthalate 
(DEPH), performed transcriptomic analysis of purified G1 and G2 prospermatogonia, found 
statistically significant overlap neither between upregulated genes in G1 and G2 nor between 
downregulated genes in the two prospermatogonia samples, and concluded that the EDCs do not 
cause TEI. My reanalysis of their data [2] using hypergeometric distribution probability showed 
that the overlap becomes highly significant if both up- and down-regulated genes are combined 
together, and suggested, citing known examples of phenotypic variability observed across 
generations in epigenetic inheritance, that an overlap of differentially expressed genes, 
irrespective of directionality of expression change, supports TEI. A comparison between Iqbal et 
al.'s VZ and DEPH associated differentially expressed genes with previously reported 
differentially expressed genes in embryonic and adult tissues drawn from multiple generations of 
rats, in studies investigating transgenerational effects of VZ, showed a highly significant VZ-VZ, 
not VZ-DEPH, overlap. This further supported occurrence of TEI. Recently, in response to my 
criticism of Iqbal et al.'s claim, Szabó's [3] reanalyzed the gene expression data and claimed that 
my statistical calculations were wrong. She also asserts that the evidence that I cited in support 
of observing variable directionality of phenotypic expression across generations are not relevant 
to gene expression studies. Here, both of her concerns are addressed for clarification.       
 
 
 
Data reanalysis 
Szabó's [3] first objects that I selectively focused on genes identified at reduced statistical 
stringency by Iqbal et al. [1]. It is however notable that Iqbal et al. themselves used these genes 
in Fisher's exact test to arrive at the conclusion that a significantly higher number of the common 
changes between generations occurred in the opposite direction. This objection is therefore not 
relevant. On the contrary, Iqbal et al.'s above conclusion reiterates the core concern, that why 
should gene changes in opposite direction be assumed as negative evidence in transgenerational 
inheritance. Next, Szabó asserts that Iqbal et al.'s conclusion, that they did not find any evidence 
of TEI, was not erroneous, as claimed by me, mainly because she finds my overlap analysis 
incorrect. In support, Szabó produces two data sets, Tables 1 and 2 [3], countering Figures 1 and 
2 [2] of my analysis, respectively. The Table 1 [3] shows the hypergeometric p values for 
significance of overlap between the combined set of up- and down-regulated genes in the first 
and the second generation, as does my Figure 1 [2]. A comparison of the data published in my 
Figure 1 [2] and that in Szabó's Table 1 [3] clearly shows (Figure 1) that Szabó's result does not 
dispute my finding, that differentially expressed genes between generations overlap significantly. 
 
The rest of the data shown in Table 1 [3] relate to comparisons between genes that changed in 
expression either in the same or in the opposite direction across generations, results that are not 
directly related to my analysis. Nevertheless, these comparisons further support TEI, because a 
highly significant (p = 8.94E-04) overlap is reported for genes that changed in the opposite 
direction between generations in VZ group. Had there been no transgenerational effects, a 
significant overlap would not have been observed. Szabó's explanation that genes changing in 
opposite direction may indicate a slight overcompensation in the erasure process is not supported 
by Iqbal et al.'s data. Though Iqbal et al. performed extensive DNA methylation analysis, they 
found no evidence of methylation changes across generations. Moreover, should Szabó's 
speculation stand valid, would it not beg the question as to why overcompensation will be 
observed if there is no transgenerational effect? Regarding Szabó's objection [3] that adjustment 
for multiple hypothesis testing was not performed by me [2], it is noted here that the significant p 
values shown in her Table 1 [3] as well as my Figure 1 [2] would all remain highly significant 
even after Bonferroni correction. For example, for the six hypotheses that have been tested in 
Table 1, the nominal p values 1.16E-06, 4.04E-08, and 8.94E-04 become 6.96E-06, 2.42E-07, 
and 0.005, all significant, after adjustment. Cumulatively, Szabó's Table 1 supports, not 
contardicts, my Figure 1 that provided evidence in favor of TEI. 
 
As regards Szabó's Table 2, she wrongly counted the cumulative numbers of differentially 
expressed genes in 36 studies, and of Iqbal et al.'s VZ and DEPH genes common to these studies. 
She simply added all individual gene counts to arrive at cumulative numbers, without removing 
the duplicate entries. Second, in calculating hypergeometric probabilities, she considered a 
population of 21041 mouse genes, the total number of genes in the mouse microarrays Iqbal et 
al. used in their mouse study. However, the other 36 studies with which Iqbal et al.'s genes are 
compared were rat studies that used rat microarrays, with different gene coverage. Clearly, a 
neutral population should have been used to enable normalization of mouse and rat genes. 
Human genome was used in my analysis exactly to fulfill this requirement. 
 
Regarding Szabó's criticism that why did my Figure 2, unlike one of my previous, unrelated 
papers, show significance values only for all the 36 studies combined, and not for each of these 
studies individually, it is noted here that the previous paper was related to miRNA counts 
wherein a zero "sample success" was not observed for any individual study, with the number of 
successes observed always being a positive number, mostly in tens or hundreds. In contrast, data 
related to Figure 2 frequently suffered from zero or very small sample success (Table 1). Given 
that p value in general is dependent on sample size, significance of gene overlaps is a function of 
gene counts, and increased overlapping significance with growing gene counts is suggestive of 
the significance observed being a true signal [4], my analysis reported p values for all the studies 
combined. The extent of overlap (fold enrichment) was nonetheless provided in the figure for 
individual studies. As regards adjustment for multiple testing, it was obvious from the figure that 
the nominal VZ-VZ overlapping significance shown (p = 0.0002) can easily survive an 
adjustment. Even when the p value shown is adjusted for 38 tests, representing 36 individual and 
2 combined studies, using Bonferroni correction, the overlap remains significant (p = 0.007). 
Regarding accompanying change in VZ-DEPH comparison, the change from significant nominal 
p (0.01) to insignificant adjusted p (0.38) is an expected one, as the two EDCs are expected to 
cause different gene expression effects at transcriptome level. Further, even when the probability 
of drawing the given number of successes at least, not exactly, is calculated, the VZ-VZ overlap 
shown in my figure remains significant. In this calculation, the nominal p value is obtained as 
0.00057, and adjusted p as 0.021. Together, Szabó's Table 2 is found invalid, with my Figure 2 
data supporting TEI remaining justified. 
 
Prior evidence 
Szabó argues that the evidence that I cited in support of the possibility that gene expression 
changes may show directional variability across generations in transgenerational epigenetic 
inheritance is inappropriate. Primarily, her concern is that a paper that I referred to showed 
directional change in gene expression between F1/F2 and F3, not between F1 and F2. She asserts 
that a lack of phenotype under investigation, primordial germ cell defects, in F3 renders this 
example unacceptable. Is not altered gene expression a phenotype in itself? Then, is not 
observing this molecular phenotype in F3 an evidence of TEI? Obviously, the answers to these 
questions are in the affirmative. Szabó's objection is hence not supported. Her next objection is 
that another paper that I cited relates to expression of miRNA, not mRNA, and to the worm C. 
elegans, not mammals. How it is that miRNA expression change across generations is acceptable 
as evidence for TEI, whereas that of mRNA not? Also, is not C. elegans an established model of 
TEI? Moreover, as it is often difficult to cite all relevant papers in an article, the examples that I 
referred to were only illustrative, not exhaustive. The examples nonetheless conveyed the 
principal observation, that phenotypes, molecular or otherwise, can vary in directionality across 
generations in epigenetic inheritance. Given this, Szabó's assertion that there exists no support 
for directionality change in phenotypic expression in TEI does not hold.          
 
Conclusion 
Szabó's objections to my criticism of Iqbal et al.'s claim are not supported. Her data reanalysis is 
not accurate Also, her assertion that gene expression alterations do not represent a phenotype is 
grossly misplaced.   
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Figure 1 
Comparison of G1R-G2R gene overlap data. Whereas my analysis [2] presented the probability 
of drawing the given number of successes exactly, Szabó [3] calculated the probability of 
drawing the given number of successes at least. *indicates a note in the legend of my Figure 1 
[2] clearly stating that the p value remains highly significant even when the probability is 
calculated for the given number of successes at least. 
  
Table 1. Details of gene overlap analysis presented in Figure 2 [2] 
Previous VZ dataset
*
 
Changed 
genes in 
dataset
#
 
Common 
with Iqbal 
et al.'s VZ 
genes
** $
 
Fold 
enrichment 
Common 
with Iqbal 
et al.'s 
DEPH 
genes
** @
 
Fold 
enrichment 
 
F1 embryo male testis 49 0 
 
0 
 F1 embryo E13 male 
testis 195 5 2.3 3 1.1 
F1 embryo E14 male 
testis 106 2 1.7 2 1.3 
F1 embryo E16 male 
testis 102 3 2.7 1 0.7 
F2 embryo male testis 49 0 
 
0 
 F3 embryo male testis 29 0 
 
0 
 F3 adult male sertoli cells 285 9 2.9 9 2.2 
F3 adult female granulosa 
cells 326 7 1.9 7 1.5 
F3 adult female heart 92 0 
 
2 1.5 
F3 adult female kidney 337 9 2.4 9 1.9 
F3 adult female liver 170 0 
 
1 0.4 
F3 adult female uterus 176 5 2.6 5 2.0 
F3 adult male heart 75 1 1.2 2 1.9 
F3 adult male kidney 69 0 
 
1 1.0 
F3 adult male liver 43 2 4.3 1 1.6 
F3 adult male prostate 641 12 1.7 9 1.0 
F3 adult male seminal 
vesicle 139 0 
 
0 
 F3 adult female ovary 1939 30 1.4 31 1.1 
F3 adult male testis 251 3 1.1 2 0.5 
F3 adult male amygdala 137 2 1.3 1 0.5 
F3 adult male 
hippocampus 58 1 1.6 0 
 F3 adult female amygdala 60 0 
 
0 
 F3 adult female 
hippocampus 609 13 1.9 18 2.1 
F3 adult male brain 443 3 0.6 4 0.6 
F3 adult male basolateral 
amygdala 10 0 
 
1 7.2 
F3 adult male brain cortex 39 2 4.7 1 1.8 
F3 adult male 
hippocampus CA1 29 0 
 
0 
 
F3 adult male 
hippocampus CA3 97 1 0.9 1 0.7 
F3 adult female 
basolateral amygdala 29 1 3.2 0 
 F3 adult female brain 
cortex 50 0 
 
0 
 F3 adult female 
hippocampus CA1 18 1 5.1 1 4.0 
F3 adult female 
hippocampus CA3 12 0 
 
0 
 F3 adult male ventral 
prostate 438 5 1.1 9 1.4 
F3 adult male prostate 
epithelial cells 141 2 1.3 0 
 F3 embryo E13 male 
primordial germ cells 175 3 1.6 1 0.4 
F3 embryo E16 male 
prospermatogonia 77 0 
 
0 
 Cumulative (36 studies) 4066 64 1.5 69 1.2 
 
*rat study; **mouse study; #within total population, 18865 human genes; $203 genes, within total 
population; @262 genes, within total population 
 
 
